Table 3.
Group A | Group B | p Values | |
---|---|---|---|
Anosmia (n, %) | 44 (27.2%) | 118 (72.8%) | <0.001 * |
VAS score | 8.02 (7.70–8.35) | 2.63 (2.27–2.98) | |
Ageusia (n, %) | 39 (88.6%) | 1 (0.8%) | <0.001 * |
VAS score | 7.43 (7.03–7.83) | 2.47 (2.11–2.83) | |
Nasal obstruction (n, %) | 8 (18.2%) | 5 (4.2%) | 0.007 * |
VAS score | 4.91 (4.19–5.63) | 2.32 (1.94–2.70) | |
Rhinorrea (n, %) | 0 (0%) | 3 (2.5%) | 0.286 |
VAS score | 3.86 (3.35–4.38) | 1.77 (1.42–2.12) | |
Postnasal drip (n, %) | 0 (0%) | 4 (3.4%) | 0.216 |
VAS score | 3.50 (3.00–4.00) | 1.57 (1.11–1.92) | |
Sneezes (n, %) | 1 (2.3%) | 1 (0.8%) | 0.465 |
VAS score | 3.18 (2.61–3.75) | 1.72 (1.40–2.04) | |
Headache (n, %) | 11 (25%) | 1 (0.8%) | <0.001 * |
VAS score | 4.66 (3.86–5.45) | 2.04 (1.67–2.41) |